基于纳米技术的肺部疾病治疗
本文综述了纳米医学在肺部疾病临床转化中的趋势与进展,涵盖肺癌、囊性纤维化、哮喘、细菌感染和慢阻肺等领域。纳米医学有望通过治疗药物递送、疫苗开发和纳米技术医学检测的新方法革新医学实践。
要点
- 纳米医学在肺部疾病中的应用是相对较新的交叉学科领域,近10年快速发展。
- 纳米医学有望通过药物递送、疫苗开发和纳米检测革新医学实践。
- 综述聚焦肺癌、囊性纤维化、哮喘、细菌感染和慢阻肺的临床转化。
核心结论
- 纳米医学有望通过治疗药物递送、疫苗开发和纳米技术医学检测的新方法革新医学实践。
- 基于纳米的方法将在不久的将来改变肺部疾病诊断和治疗的方式。
研究设计与样本
- 综述类文章,聚焦纳米医学在肺部疾病临床转化中的当前趋势和发展。
主要发现
- 近10年纳米医学在肺部疾病中的应用作为相对较新的交叉学科领域快速发展。
- 有前景的研究成果提示纳米医学将革新医学实践。
临床怎么用
- 纳米医学在肺癌、囊性纤维化、哮喘、细菌感染和慢阻肺等肺部疾病中具有临床转化前景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nanomedicine is a multidisciplinary research field with an integration of traditional sciences such as chemistry, physics, biology and materials science. The application of nanomedicine for lung diseases as a relatively new area of interdisciplinary science has grown rapidly over the last 10 years. Promising research outcomes suggest that nanomedicine will revolutionise the practice of medicine, through the development of new approaches in therapeutic agent delivery, vaccine development and nanotechnology-based medical detections. Nano-based approaches in the diagnosis and treatment of lung diseases will, in the not too distant future, change the way we practise medicine. This review will focus on the current trends and developments in the clinical translation of nanomedicine for lung diseases, such as in the areas of lung cancer, cystic fibrosis, asthma, bacterial infections and COPD.
引用
- Doroudian M, MacLoughlin R, Poynton F, et al. Nanotechnology based therapeutics for lung disease. Thorax. 2019. PMID: 31285360. doi:10.1136/thoraxjnl-2019-213037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。